- Article number:
- 1672-0571(2023)03-0025-05
- ZTFLH:
- R256.1
- Code:
- A
References:
［1］Remes-Troche JM，Ramos-de-la-Medina A，ManríquezReyes M，et al.Initial Gastrointestinal Manifestations in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection in 112 Patients From Veracruz in Southeastern Mexico［J］.Gastroenterology，2020，159(3):1179-1181.
［2］Cholankeril G，Podboy A，Aivaliotis VI，et al.High Prevalence of Concurrent Gastrointestinal Manifestations in Patients With Severe Acute Respiratory Syndrome Coronavirus 2：Early Experience From California［J］.Gastroenterology，2020，159(2):775-777.
［3］陆敏,樊欣钰,方小谦,等.118例新型冠状病毒肺炎消化系统症状分布研究［J］.江苏中医药,2021,53(4):34-36.
［4］Lak E，Sheikholeslami SA，Ghorbi MD，et al.Association between gastrointestinal symptoms and disease severity in patients with COVID-19 in Tehran City，Iran［J］.Prz Gastroenterol，2022，17(1):52-58.
［5］Khan MU，Mushtaq K，Alsoub DH，et al.Digestive system involvement and clinical outcomes among COVID-19 patients：A retrospective cohort study from Qatar［J］.World J Gastroenterol，2021，27(46):7995-8009.
［6］Lipták P，Banovcin P，Rosoíanka R，et al.A machine learning approach for identification of gastrointestinal predictors for the risk of COVID-19 related hospitalization［J］.Peer J，2022,10:e13124.
［7］王亮,王鹏,侯晓圆,等.重型和危重型新型冠状病毒肺炎病机特点探析［J］.山东中医药大学学报,2022,46(5):587-592.
［8］Wang Y，Li Y，Zhang Y，et al.Are gastrointestinal symptoms associated with higher risk of Mortality in COVID-19 patients? A systematic review and metaanalysis［J］.BMC Gastroenterol,2022,22(1):106.
［9］吴文昊.凝血功能异常对新型冠状病毒肺炎重症患者的预测和预后价值［D］.重庆：中国人民解放军陆军军医大学,2022.
［10］Han C，Duan C，Zhang S，et al.Digestive Symptoms in COVID-19 Patients With Mild Disease Severity：Clinical Presentation，Stool Viral RNA Testing，and Outcomes［J］.Am J Gastroenterol，2020,115(6):916-923.
［11］邵文雪,许二平,郭选贤,等.基于温病辨证体系探讨新型冠状病毒肺炎辨治［J］.河南中医,2022,42(9):1309-1313.
［12］王玉光，齐文升，马家驹，等.新型冠状病毒肺炎中医临床特征与辨证治疗初探［J］.中医杂志，2020，61(4)：281-285.
［13］朱为坤,张喜奎.《温疫论》阳气郁滞理论及其对新型冠状病毒肺炎防治的启示［J］.北京中医药大学学报,2022,45(8):775-779.
［14］管振,张林.“邪伏膜原”理论与达原饮初探［J］.辽宁中医药大学学报,2021,23(2):177-180.
［15］吴有性.温疫论［M］.张志斌,整理.北京:人民卫生出版社,2007
［16］罗雄,刘芳.从新型冠状病毒肺炎浅析中医思维［J］.云南中医中药杂志,2022,43(9):20-22.
［17］朱紫尧,何婧琳,李兆福,等.从《温疫论》达原饮证转归及组方看“既病防变”思想［J］.四川中医,2021,39(5):20-22.
［18］马家驹,王玉光.膜原及达原饮的临床指征探析［J］.北京中医药大学学报,2020,43(6):463-468.
［19］潘芳,庞博,梁腾霄,等.新型冠状病毒肺炎中医防治思路探讨［J］.北京中医药,2020,39(2):125-130.，
［20］Qiu Q，Huang Y，Liu X，et al.Potential therapeutic effect of traditional Chinese medicine on coronavirus disease 2019：a review［J］.Frontiers in pharmacology，2020，11：1638.
［21］Akbari H，Tabrizi R，Lankarani KB，et al.The role of cytokine profile and lymphocyte subsets in the severity of coronavirus disease 2019 (COVID-19)：A systematic review and metaanalysis［J］.Life Sci，2020,258:118167.
［22］朱家旺,赵寻,武强彬,等.103例新型冠状病毒肺炎患者舌象变化的临床分析［J］.天津中医药,2021,38(7):830-832.
［23］周耿标,黄东晖,蔡彦,等.新型冠状病毒肺炎患者舌象特征与临床分型的关系［J］.中医杂志,2020,61(19):1657-1660.
［24］惠彩霞,白雪峰,李元军,等.基于舌象理论中医药防治新型冠状病毒肺炎的应用探析［J］.现代中医药,2022,42(4):59-64.
［25］方邦江,齐文升,杨志旭,等.《新型冠状病毒肺炎诊疗方案(试行第九版)》中医治疗更新及其对奥密克戎变异株感染防治指导作用［J］.陕西中医药大学学报,2022,45(3):1-4.
Memo
基金项目：国家自然科学基金项目（82174240）；上海市卫健委科研项目［ZY(2018-2020)-ZWB-1001-CPJS34］；上海市嘉定区卫健委中医药科研课题（2020-KY-ZYY-06）